198 related articles for article (PubMed ID: 29602230)
1. Alterations of polyunsaturated fatty acid metabolism in ovarian tissues of polycystic ovary syndrome rats.
Huang R; Xue X; Li S; Wang Y; Sun Y; Liu W; Yin H; Tao T
J Cell Mol Med; 2018 Jul; 22(7):3388-3396. PubMed ID: 29602230
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Novel Lipid Profiles in PCOS: Do Insulin and Androgen Oppositely Regulate Bioactive Lipid Production?
Li S; Chu Q; Ma J; Sun Y; Tao T; Huang R; Liao Y; Yue J; Zheng J; Wang L; Xue X; Zhu M; Kang X; Yin H; Liu W
J Clin Endocrinol Metab; 2017 Mar; 102(3):810-821. PubMed ID: 27886515
[TBL] [Abstract][Full Text] [Related]
3. Role of PCSK9 in lipid metabolic disorders and ovarian dysfunction in polycystic ovary syndrome.
Wang M; Zhao D; Xu L; Guo W; Nie L; Lei Y; Long Y; Liu M; Wang Y; Zhang X; Zhang L; Li H; Zhang J; Yuan D; Yue L
Metabolism; 2019 May; 94():47-58. PubMed ID: 30768966
[TBL] [Abstract][Full Text] [Related]
4. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
Qiu Z; Dong J; Xue C; Li X; Liu K; Liu B; Cheng J; Huang F
J Ethnopharmacol; 2020 Mar; 250():111965. PubMed ID: 31185267
[TBL] [Abstract][Full Text] [Related]
5. Administration of a VIP-antagonist in vivo modifies ovarian hormone secretion in a rat model with polycystic ovary syndrome.
Morales-Ledesma L; Trujillo Hernández A; Ramírez MI; Rosas G; Linares R
Life Sci; 2021 Jan; 265():118792. PubMed ID: 33220286
[TBL] [Abstract][Full Text] [Related]
6. Activation of TGF-β1/Smad3 signaling pathway inhibits the development of ovarian follicle in polycystic ovary syndrome by promoting apoptosis of granulosa cells.
Shen H; Wang Y
J Cell Physiol; 2019 Jul; 234(7):11976-11985. PubMed ID: 30536903
[TBL] [Abstract][Full Text] [Related]
7. Expression of angiopoietin-like protein 2 in ovarian tissue of rat polycystic ovarian syndrome model and its correlation study.
Wang D; Guo Y; Chai S; Shen K; Li Y; Zhao R
Reprod Biol Endocrinol; 2020 Sep; 18(1):94. PubMed ID: 32988397
[TBL] [Abstract][Full Text] [Related]
8. Can polyunsaturated fatty acids regulate Polycystic Ovary Syndrome via TGF-β signalling?
D Prabhu Y; Valsala Gopalakrishnan A
Life Sci; 2021 Jul; 276():119416. PubMed ID: 33774033
[TBL] [Abstract][Full Text] [Related]
9. Ovarian steroidal response to gonadotropins and beta-adrenergic stimulation is enhanced in polycystic ovary syndrome: role of sympathetic innervation.
Barria A; Leyton V; Ojeda SR; Lara HE
Endocrinology; 1993 Dec; 133(6):2696-703. PubMed ID: 8243293
[TBL] [Abstract][Full Text] [Related]
10. Dehydroepiandrosterone stimulates inflammation and impairs ovarian functions of polycystic ovary syndrome.
Li Y; Zheng Q; Sun D; Cui X; Chen S; Bulbul A; Liu S; Yan Q
J Cell Physiol; 2019 May; 234(5):7435-7447. PubMed ID: 30580448
[TBL] [Abstract][Full Text] [Related]
11. Abnormal expression of HSP70 may contribute to PCOS pathology.
Wu G; Hu X; Ding J; Yang J
J Ovarian Res; 2019 Aug; 12(1):74. PubMed ID: 31399035
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome.
Leblanc S; Battista MC; Noll C; Hallberg A; Gallo-Payet N; Carpentier AC; Vine DF; Baillargeon JP
Endocrinology; 2014 Sep; 155(9):3684-93. PubMed ID: 24971613
[TBL] [Abstract][Full Text] [Related]
13. Trace glucose and lipid metabolism in high androgen and high-fat diet induced polycystic ovary syndrome rats.
Zhai HL; Wu H; Xu H; Weng P; Xia FZ; Chen Y; Lu YL
Reprod Biol Endocrinol; 2012 Jan; 10():5. PubMed ID: 22276997
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone is effective for multiple phenotyepes of the Zucker fa/fa rat with polycystc ovary morphology and insulin resistance.
Morishita M; Endo T; Baba T; Kuno Y; Ikeda K; Kiya T; Honnma H; Saito T
J Ovarian Res; 2018 Mar; 11(1):24. PubMed ID: 29580285
[TBL] [Abstract][Full Text] [Related]
15. Beneficial phytoestrogenic effects of resveratrol on polycystic ovary syndromein rat model.
Zhang N; Zhuang L; Gai S; Shan Y; Wang S; Li F; Chen L; Zhao D; Liu X
Gynecol Endocrinol; 2021 Apr; 37(4):337-341. PubMed ID: 32851887
[TBL] [Abstract][Full Text] [Related]
16. The characterization of obese polycystic ovary syndrome rat model suitable for exercise intervention.
Wu C; Lin F; Qiu S; Jiang Z
PLoS One; 2014; 9(6):e99155. PubMed ID: 24905232
[TBL] [Abstract][Full Text] [Related]
17. Baicalin ameliorates polycystic ovary syndrome through AMP-activated protein kinase.
Wang W; Zheng J; Cui N; Jiang L; Zhou H; Zhang D; Hao G
J Ovarian Res; 2019 Nov; 12(1):109. PubMed ID: 31722718
[TBL] [Abstract][Full Text] [Related]
18. Angiopoietins/TIE2 system and VEGF are involved in ovarian function in a DHEA rat model of polycystic ovary syndrome.
Abramovich D; Irusta G; Bas D; Cataldi NI; Parborell F; Tesone M
Endocrinology; 2012 Jul; 153(7):3446-56. PubMed ID: 22577112
[TBL] [Abstract][Full Text] [Related]
19. Serum fatty acid profiles associated with metabolic risk in women with polycystic ovary syndrome.
Tian Y; Zhang J; Li M; Shang J; Bai X; Zhang H; Wang Y; Chen H; Song X
Front Endocrinol (Lausanne); 2023; 14():1077590. PubMed ID: 37065734
[TBL] [Abstract][Full Text] [Related]
20. The phytoestrogen, quercetin, in serum, uterus and ovary as a potential treatment for dehydroepiandrosterone-induced polycystic ovary syndrome in the rat.
Jafari Khorchani M; Zal F; Neisy A
Reprod Fertil Dev; 2020 Feb; 32(3):313-321. PubMed ID: 31661670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
